CompanyInvestor RelationsStem Cell StorageCell ExpansionCell TherapiesResearch and DevelopmentCompany NewsScientific NewsContact
    
 
  • Company
  • Shareholder
  • Share Price
  • Analyst
  • Financial Reporting
  • Accounting policies
  • Calendar
  • Investor News
  • Contact
    		•
    Investor Relations / Investor News

    Announcements

    Date Title Summary 
    07/05/2008Holding(s) in CompanyTR-1: Notifications of Major Interests in Shares
    28/04/2008Transaction in Own SharesOn Friday 25 April 2008, Cryo-Save Group N.V. (the "Company") acquired 200,000 of its ordinary shares at an average price of 202 pence per ordinary share. The ordinary shares purchased will be held in treasury by the Company.
    25/04/2008Transaction in Own SharesCryo-Save Group N.V. (the "Company") yesterday acquired 20,000 of its ordinary shares at an average price of 200 pence per ordinary share. The ordinary shares purchased will be held in treasury by the Company.
    21/04/2008Transaction in Own SharesCryo-Save Group N.V. (the "Company") today acquired 113,000 of its ordinary shares at an average price of 200 pence per ordinary share. The ordinary shares purchased will be held in treasury by the Company.
    18/04/2008Transaction in Own Shares / Total Voting RightsCryo-Save Group N.V. (the "Company") yesterday acquired 8,000 of its ordinary shares at an average price of 187.5 pence per ordinary share. The ordinary shares purchased will be held in treasury by the Company.
    15/04/2008Transaction in Own Shares / Total Voting RightsCryo-Save Group N.V. (the "Company") yesterday acquired 10,000 of its ordinary shares at an average price of 164 pence per ordinary share. The ordinary shares purchased will be held in treasury by the Company.
    14/04/2008Transaction in Own Shares / Total Voting RightsOn Friday 11 April 2008, Cryo-Save Group N.V. (the "Company") acquired 10,000 of its ordinary shares at an average price of 165 pence per ordinary share. The ordinary shares purchased will be held in treasury by the Company.
    11/04/2008Transaction in Own SharesCryo-Save Group N.V. (the "Company") yesterday acquired 94,000 of its ordinary shares at an average price of 164 pence per ordinary share. The ordinary shares purchased will be held in treasury by the Company.
    10/04/2008Transaction in Own SharesCryo-Save Group N.V. (the "Company") yesterday acquired 25,000 of its ordinary shares at an average price of 154 pence per ordinary share. The ordinary shares purchased will be held in treasury by the Company.
    10/04/2008Director/PDMR ShareholdingCryo-Save Group N.V. (the "Company") announces that it was notified on 9 April 2008 that Johan Goossens, a Non-Executive Director of the Company, yesterday purchased 1,450,000 ordinary shares in the Company at 160 pence per ordinary share.
    09/04/2008Transaction in Own SharesCryo-Save Group N.V. (the "Company") yesterday acquired 745,000 of its ordinary shares at an average price of 147 pence per ordinary share. The ordinary shares purchased will be held in treasury by the Company.
    08/04/2008Preliminary resultsCryo-Save Group N.V. (AIM: CRYO, “Cryo-Save” or “the Group”), Europe’s leading adult stem cell storage bank, has published its preliminary results for the year to 31 December 2007 as well as its storage and new clients figures for Q1 2008.
    13/03/2008Launch in IndiaCryo-Save Group N.V. (AIM: CRYO, “Cryo-Save” or “the Group”), Europe’s largest adult stem cell storage bank, has established an Indian operation, Cryo-Save India Private Ltd ("Cryo-Save India"), will build a new storage laboratory in Belgium and has acquired its South African distributor CRYOCLINIC (Pty) Ltd ("Cryoclinic").
    07/03/2008Notice of ResultsCryo-Save Group NV, (AIM: CRYO, ‘the Company’), Europe's largest adult stem cell storage bank, which was admitted to AIM on 6 November 2007, will be publishing its first Preliminary results for the year ended 31 December 2007 on Tuesday, 8 April 2008.
    08/02/2008Transaction in Own Shares – Total Voting RightsCryo-Save Group N.V. (the "Company") yesterday acquired 66,500 of its ordinary shares at an average price of 190 pence per ordinary share.
    04/02/2008Transaction in Own Shares – Total Voting RightsOn Friday 1st February Cryo-Save Group N.V. (the "Company") acquired 56,000 of its ordinary shares at an average price of 189 pence per ordinary share.
    01/02/2008Transaction in Own Shares – Total Voting RightsCryo-Save Group N.V. (the "Company") yesterday acquired 62,500 of its ordinary shares at an average price of 187 pence per ordinary share.
    31/01/2008Acquisition of Hungarian distributor and year-end trading updateCryo-Save Group N.V. (AIM: CRYO, "Cryo-Save" or "the Group"), Europe's largest adult stem cell storage bank, announces that it is publishing a trading update for the year ended 31 December 2007 and that it has acquired its Hungarian distributor, Sejtbank. Cryo-Save was admitted to AIM on 6 November 2007.
    24/12/2007Transaction in Own SharesCryo-Save Group N.V. (the "Company"), on Friday 21 December 2007, acquired 50,000 of its ordinary shares at an average price of 210 pence per ordinary share.
    21/12/2007Transaction in Own SharesCryo-Save Group N.V. (the "Company") yesterday acquired 25,000 of its ordinary shares at an average price of 208 pence per ordinary share.
    20/12/2007Transaction in Own SharesCryo-Save Group N.V. (the "Company") yesterday acquired 80,000 of its ordinary shares at an average price of 206 pence per ordinary share.
    10/12/2007Director/PDMR ShareholdingCryo-Save Group N.V. ("Cryo-Save" or "the Company"), Europe's largest adult stem cell storage bank, announces that on 7 December 2007 the Company granted options to subscribe for ordinary shares in the Company under the Cryo-Save Group 2007 Share Option Scheme.
    13/11/2007Major Interests in SharesNotification of major interests in shares.
    06/11/2007Cryo-Save Group N.V. First day of dealingsCryo-Save Group N.V. (“Cryo-Save”, “the Group” or “the Company”), Europe’s largest adult stem cell storage bank, announces the commencement of dealings in its Ordinary Shares on AIM today under the ticker code CRYO.L and the ISIN number of NL0006091969.
    01/11/2007Cryo-Save Group N.V.: Admission to AIM with market capitalisation of £101.2mCryo-Save Group N.V. (“Cryo-Save”, “the Group” or “the Company”), Europe’s largest adult stem cell storage bank, is to be admitted to AIM with a market capitalisation of £101.17 million. The Group has raised £26.54 million, before expenses, via a placing of shares at 210p per share with institutional investors. Trading in Cryo-Save shares is expected to start on Tuesday 6 November 2007.
    		  
      europe flag
    Europe's leading family stem cell bank - 4 laboratories - 37 countries -
    3 continents


    Use of this website signifies your agreement to the Disclaimer.
    ©2008 Cryo-Save Group N.V. All rights reserved.